NCT05122962 Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
| NCT ID | NCT05122962 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Tetralogy of Fallot |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-11-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-11-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)
Eligibility Criteria
Inclusion Criteria: * Moderate (or greater) PR based on quantitative Doppler echocardiography. * Repaired TOF * Congenital Heart Disease diagnosis including but not limited to Ebstein's anomaly, coarctation of the aorta (COA), Fontan palliation, transposition of the great arteries, congenitally corrected transposition of the great arteries. Exclusion Criteria: * Pregnant Women * Unable to undergo CMRI
Contact & Investigator
Alexander Egbe, MBBS, MPH
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05122962 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tetralogy of Fallot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05122962 currently recruiting?
Yes, NCT05122962 is actively recruiting participants. Contact the research team at RSTACHDRESPRG@mayo.edu for enrollment information.
Where is the NCT05122962 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05122962 clinical trial?
NCT05122962 is sponsored by Mayo Clinic. The principal investigator is Alexander Egbe, MBBS, MPH at Mayo Clinic. The trial plans to enroll 300 participants.